Daily aspirin gains new attention in COVID-19 fight while antiviral drug trial stopped Oct. 26, 2020 By Michael Fitzhugh No Comments Interest in testing the mettle of three widely available drugs against COVID-19 gained traction Monday, led by suggestions that daily low-dose aspirin might lower the risks of complications and death from the disease. Read More